Literature DB >> 28547573

Results of lumbar spondylodeses using different bone grafting materials after transforaminal lumbar interbody fusion (TLIF).

Nicolas Heinz vonderHoeh1, Anna Voelker1, Christoph-Eckhard Heyde2.   

Abstract

PURPOSE: Can a mixture of hydroxyapatite (HA) and autologous bone from decompression sites produce similar results when used for transforaminal lumbar interbody fusion (TLIF)? In the current literature, autologous iliac crest bone grafts (ICBGs) have been reported the gold standard for this procedure. Indeed, to date, no clinical data have confirmed that a mixture of equal volumes of HA and local autologous bone produce similar results in term of fusion as the same volume of autologous ICBG alone.
METHODS: Study design/setting This study was approved by the local ethics committee and completed in a prospective, randomized, single-blinded manner. The results of lumbar fusion using TLIF and different bone grafting materials were compared. Patient sample The patient sample included patients with spinal lumbar degenerative disease. Outcome measures The clinical outcome was determined using the Oswestry Low Back Pain Disability Questionnaire (ODI) and Visual Analog Scale (VAS). The radiological outcomes and fusion rates were determined with radiographs evaluated using the McAfee criteria and computed tomography (CT) data evaluated by the Williams criteria. Three blinded investigators (one radiologist and two orthopedic surgeons) assessed the data. The secondary variables included donor site morbidity. Methods The patients were admitted to our department for orthopedic surgery with degenerative lumbar pathologies (L2-S1) that required stabilization in one or two segments using a TLIF procedure. The patients were 18-80 years old. Only those patients who had degenerative lumbar pathologies and agreed to be educated about the study were included. The patients were divided into the following two randomized groups: group A: TLIF procedure using autologous ICBGs alone; and group B: TLIF procedure using local bone from decompression site mixed with hydroxyapatite. Each group received equal graft volumes. The mixture in group B consisted of equal volumes of local autograft (5 cc) and synthetic bone (5 cc). A graft volume of 10 cc was used at each fusion level. The patients were followed up at three appointments at 1.5, 6 and 12 months postoperatively. Every patient received detailed education about the course of the study.
RESULTS: Forty-eight patients finished the study (2 patients dropped out). The radiographic fusion rate did not significantly differ between the two groups. Based on the CT criteria, 83.3% of the patients showed fusion in both groups after 12 months. Furthermore, 95.3% of the patients in group A and 91.7% of the patients in group B showed bony spondylodeses according to the radiographic criteria at the 12-month follow-up. The donor site morbidity consisted of one patient with a wound infection and one with a hematoma in group A and two patients with persistent pain in group B. Group A also included one patient with cage subsidence of 4 mm and archived fusion after 12 months. In group B, one patient had a pedicle screw breakage and achieved fusion after 6 months. The clinical outcomes were similar between the two groups. In both groups, the VAS and ODI data improved during the follow-up period (p < 0.05). No patients required additional surgeries.
CONCLUSIONS: Both groups demonstrated equivalent clinical outcomes. HA and autologous bone from decompression sites can achieve similar fusion rates to those achieved with identical volumes of the gold standard autologous graft. The graft mixture can be used for one- or two-level lumbar spondylodeses to avoid donor site morbidity.

Entities:  

Keywords:  Bone graft; Fusion rate; Hydroxyapatite; Iliac crest; TLIF

Mesh:

Year:  2017        PMID: 28547573     DOI: 10.1007/s00586-017-5145-0

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  37 in total

1.  Lumbar interbody fusion using the Brantigan I/F cage for posterior lumbar interbody fusion and the variable pedicle screw placement system: two-year results from a Food and Drug Administration investigational device exemption clinical trial.

Authors:  J W Brantigan; A D Steffee; M L Lewis; L M Quinn; J M Persenaire
Journal:  Spine (Phila Pa 1976)       Date:  2000-06-01       Impact factor: 3.468

2.  Fusion rate according to mixture ratio and volumes of bone graft in minimally invasive transforaminal lumbar interbody fusion: minimum 2-year follow-up.

Authors:  Jae-Sung Yoo; Sang-Hyuk Min; Sung-Hyun Yoon
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-09-13

3.  The efficacy of porous hydroxyapatite bone chip as an extender of local bone graft in posterior lumbar interbody fusion.

Authors:  Hyoungmin Kim; Choon-Ki Lee; Jin-Sup Yeom; Jae-Hyup Lee; Ki-Ho Lee; Bong-Soon Chang
Journal:  Eur Spine J       Date:  2011-12-03       Impact factor: 3.134

Review 4.  Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 16: bone graft extenders and substitutes as an adjunct for lumbar fusion.

Authors:  Michael G Kaiser; Michael W Groff; William C Watters; Zoher Ghogawala; Praveen V Mummaneni; Andrew T Dailey; Tanvir F Choudhri; Jason C Eck; Alok Sharan; Jeffrey C Wang; Sanjay S Dhall; Daniel K Resnick
Journal:  J Neurosurg Spine       Date:  2014-07

5.  Comparison of plain radiographs with CT scan to evaluate interbody fusion following the use of titanium interbody cages and transpedicular instrumentation.

Authors:  Rajesh R Shah; Saeed Mohammed; Asif Saifuddin; Benjamin A Taylor
Journal:  Eur Spine J       Date:  2003-05-07       Impact factor: 3.134

6.  Bone union rate with autologous iliac bone versus local bone graft in posterior lumbar interbody fusion (PLIF): a multicenter study.

Authors:  Zenya Ito; Shiro Imagama; Tokumi Kanemura; Yudo Hachiya; Yasushi Miura; Mitsuhiro Kamiya; Yasutsugu Yukawa; Yoshihito Sakai; Yoshito Katayama; Norimitsu Wakao; Yukihiro Matsuyama; Naoki Ishiguro
Journal:  Eur Spine J       Date:  2013-01-30       Impact factor: 3.134

Review 7.  Nonunion of the spine: a review.

Authors:  Cathy Lee; Job Dorcil; Timothy E Radomisli
Journal:  Clin Orthop Relat Res       Date:  2004-02       Impact factor: 4.176

8.  Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2.

Authors:  J Kenneth Burkus; Matthew F Gornet; Thomas C Schuler; Thomas J Kleeman; Thomas A Zdeblick
Journal:  J Bone Joint Surg Am       Date:  2009-05       Impact factor: 5.284

9.  Bone grafting options for lumbar spine surgery: a review examining clinical efficacy and complications.

Authors:  Kenneth Vaz; Kushagra Verma; Themistocles Protopsaltis; Frank Schwab; Baron Lonner; Thomas Errico
Journal:  SAS J       Date:  2010-09-01

10.  Comparison of the PEEK cage and an autologous cage made from the lumbar spinous process and laminae in posterior lumbar interbody fusion.

Authors:  Bin Lin; Hui Yu; Zhida Chen; Zhuanzhi Huang; Wenbin Zhang
Journal:  BMC Musculoskelet Disord       Date:  2016-08-30       Impact factor: 2.362

View more
  4 in total

1.  Transforaminal lumbar interbody fusion with a silicon nitride cage demonstrates early radiographic fusion.

Authors:  Mitchell T Gray; Kyle P Davis; Bryan J McEntire; B Sonny Bal; Micah W Smith
Journal:  J Spine Surg       Date:  2022-03

2.  Low-frequency electromagnetic fields combined with tissue engineering techniques accelerate intervertebral fusion.

Authors:  Weigang Li; Chunwei Huang; Tian Ma; Jiachen Wang; Wenbin Liu; Jiyuan Yan; Gaohong Sheng; Ruizhuo Zhang; Hua Wu; Chaoxu Liu
Journal:  Stem Cell Res Ther       Date:  2021-02-17       Impact factor: 6.832

3.  Local Autograft Versus Iliac Crest Bone Graft PSF-Augmented TLIF in Low-Grade Isthmic and Degenerative Lumbar Spondylolisthesis.

Authors:  Ali M Abou-Madawi; Sherif H Ali; Ahmed M Abdelmonem
Journal:  Global Spine J       Date:  2020-09-11

4.  Efficacy of Biocage in treating single-segment lumbar degenerative disease in patients with high risk of non-fusion: a prospective controlled study with at least 2 years' follow-up.

Authors:  Yang Li; Yang Yu; Tian-Yong Hou; Ze-Hua Zhang; Jun-Chao Xing; Hong-Wei Lu; Rui Zhou; Peng Cheng; Jian-Zhong Xu; Wen-Jie Wu; Fei Luo
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.